Actively Recruiting
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
Led by Institute of Gastroenterology and Hepatology, Vietnam · Updated on 2026-03-25
380
Participants Needed
1
Research Sites
40 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Adherence to GERD treatment, including medication, diet, and lifestyle, is essential for symptom control and complication prevention, yet adherence rates remain low due to various demographic and clinical factors. Digital therapeutics, particularly mobile health applications, have shown promising potential in supporting chronic disease management and improving patient outcomes. The GERDCare mobile application was developed with direct input from gastrointestinal experts. It is designed to enhance treatment adherence and patient engagement by offering features such as educational resources, symptom tracking, medication reminders, and direct communication between patients and physicians. The investigators are conducting a single-center, open-label, randomized controlled trial to evaluate the effectiveness of using GERDCare in improving patient adherence. Patients are followed up after four weeks of GERD treatment.
CONDITIONS
Official Title
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Has typical GERD symptoms such as regurgitation or heartburn
- Owns a smartphone and can use smartphone applications
You will not qualify if you...
- Has acute gastrointestinal conditions like upper GI bleeding or acute peptic ulcers
- Has gastrointestinal cancer such as esophageal or gastric cancer
- Has severe chronic illnesses like heart failure, liver failure, or chronic kidney disease
- Is pregnant, abuses alcohol, or has mental health conditions that affect medication adherence or app use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Gastroenterology and Hepatology
Hanoi, Vietnam, 100000
Actively Recruiting
Research Team
B
Binh Phuc Nguyen, MD
CONTACT
H
Hang Viet Dao, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here